Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$78 – 3313
2026
Q2
$78 Hold
2
– – ﹤0.01% 3096
2026
Q1
$80 Sell
2
-17
-89% -$805 ﹤0.01% 2857
2025
Q4
$854 Hold
19
– – ﹤0.01% 2625
2025
Q3
$849 Hold
19
– – ﹤0.01% 2505
2025
Q2
$913 Buy
19
+16
+533% +$696 ﹤0.01% 2436
2025
Q1
$120 Sell
3
-1
-25% -$42 ﹤0.01% 3045
2024
Q4
$178 Hold
4
– – ﹤0.01% 2734
2024
Q3
$182 Hold
4
– – ﹤0.01% 2515
2024
Q2
$164 Buy
+4
New +$175 ﹤0.01% 1515

Other funds holding QGEN

CoreCap Advisors's QGEN Position: Q3 2026 in Review

CoreCap Advisors sold out of Qiagen (QGEN) in Q3 2026, closing a stake of 2 shares — an estimated $78 sold.

CoreCap Advisors first reported a position in QGEN in Q2 2024 and held it in 9 quarters. The position peaked at $913 in Q2 2025. 8 funds tracked by Wall St. Rank hold QGEN as of Q3 2026.

  • CoreCap Advisors reported no remaining Qiagen position as of Q3 2026 after selling out during the quarter.
  • CoreCap Advisors sold 2 Qiagen shares in Q3 2026, an estimated $78.
  • CoreCap Advisors first reported a position in Qiagen in Q2 2024 and held it in 9 quarters.
  • CoreCap Advisors's Qiagen position peaked at $913 in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Qiagen as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.